Citi analysts maintained a Buy rating on McDonald's Corporation (NYSE:MCD) shares and increased the price target to $360 from ...
TD Cowen began coverage of Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Buy rating, citing the company's strong position in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results